IRONWOOD PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $4.09 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-26
- IRONWOOD PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $4.09M, a 95.49% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $90.73M, a 10.37% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $101.22M, a 21.66% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $83.21M, a 24.77% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $4.09M 10-K · filed 2026-02-26 |
| 2024-12-31 | $90.73M 10-K · filed 2026-02-26 |
| 2023-12-31 | $101.22M 10-K · filed 2025-03-31 |
| 2022-12-31 | $83.21M 10-K · filed 2025-03-31 |
| 2021-12-31 | $66.69M 10-K · filed 2024-02-16 |
| 2020-12-31 | $51.70M 10-K · filed 2023-02-16 |
| 2019-12-31 | $38.55M 10-K · filed 2022-02-18 |
| 2018-12-31 | $24.08M 10-K · filed 2021-02-17 |
| 2017-12-31 | $26.39M 10-K · filed 2020-02-13 |
| 2016-12-31 | $17.61M 10-K · filed 2019-02-25 |
| 2015-12-31 | $10.17M 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |